K-9 in a Mouse Model of Multiple Sclerosis
In a study using a mice model of multiple sclerosis, K-9 treatment showed promising effects by preventing further neurological deficits, reversing existing paralysis and vision loss, and promoting myelin and axonal preservation in the spinal cord. Additionally, K-9 reduced serum neurofilament light chain levels, indicating less nerve damage.
- Tags
- #MSResearch
- Most relevant to
- —
Why it matters
These findings suggest that K-9 might have protective and therapeutic properties in neurodegenerative conditions like MS, highlighting a potential for novel treatments. However, the study's animal model may not fully mimic human MS, limiting direct applicability of results.
What this does not prove
The study used a mouse model of MS, which may not fully recapitulate human MS pathology.
Next milestone
No next milestone was established from the available source.
Study facts
- Study design
- Not reported
- Participants / samples
- Not reported
- Randomised
- Not reported
- Controlled
- Not reported
- Primary endpoint met
- Not reported
- Relevant MS type
- Not reported
- Publication date
- 2026-09-23
- Evidence reviewed
- Abstract only
- Regulatory approval
- Not reported
- Research areas
- Not classified
Original sources
- Primary evidenceThe nucleoside analog kamuvudine-9 shows protective and therapeutic efficacy in a mouse model of multiple sclerosis. ↗DOI: 10.1126/scitranslmed.aei2870
Supporting passages (3)
publication datePublication date: 2026-09-23
findingsK-9 promoted myelin and axonal preservation in the mouse spinal cord and abolished the increase in serum neurofilament light (NfL) chain.
limitationsTitle: The nucleoside analog kamuvudine-9 shows protective and therapeutic efficacy in a mouse model of multiple sclerosis.
AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.